LiPlasome Pharma Overview
- Year Founded
-
2001
- Status
-
Acquired/Merged
- Employees
-
17
- Latest Deal Type
-
M&A
- Financing Rounds
-
4
LiPlasome Pharma General Information
Description
Developer of drug delivery technologies designed to offer anticancer drugs and pro-drugs. The company's LiPlaCis drug is a liplasomal reformulation of anti-cancer drugs that treat cancer patients with fewer side effects, enabling them to access anti-cancer drugs in a more targeted manner.
Contact Information
Website
www.liplasome.comCorporate Office
- Venlighedsvej 1
- 2970 Horsholm
- Denmark
Corporate Office
- Venlighedsvej 1
- 2970 Horsholm
- Denmark
LiPlasome Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
LiPlasome Pharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
LiPlasome Pharma Patents
LiPlasome Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2019131546-A | Methods for treating cancer and methods for predicting drug responsiveness in cancer patients | Pending | 31-Jan-2018 | ||
| AU-2019200325-A1 | Methods for treating cancer and predicting drug responsiveness in cancer patients | Inactive | 31-Jan-2018 | ||
| CA-3031892-A1 | Methods for treating cancer and predicting drug responsiveness in cancer patients | Pending | 31-Jan-2018 | ||
| EP-3520775-A1 | Methods for treating cancer and predicting drug responsiveness in cancer patients | Inactive | 31-Jan-2018 | ||
| US-20190231795-A1 | Methods for treating cancer and predicting drug responsiveness in cancer patients | Inactive | 31-Jan-2018 | A61K31/555 |
LiPlasome Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
LiPlasome Pharma Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
LiPlasome Pharma FAQs
-
When was LiPlasome Pharma founded?
LiPlasome Pharma was founded in 2001.
-
Where is LiPlasome Pharma headquartered?
LiPlasome Pharma is headquartered in Horsholm, Denmark.
-
What is the size of LiPlasome Pharma?
LiPlasome Pharma has 17 total employees.
-
What industry is LiPlasome Pharma in?
LiPlasome Pharma’s primary industry is Drug Delivery.
-
Is LiPlasome Pharma a private or public company?
LiPlasome Pharma is a Private company.
-
What is LiPlasome Pharma’s current revenue?
The current revenue for LiPlasome Pharma is .
-
How much funding has LiPlasome Pharma raised over time?
LiPlasome Pharma has raised $8.01M.
-
Who are LiPlasome Pharma’s investors?
BankInvest Biotech Ventures, Buhl Oncology, East West Capital Partners, LEO Pharma, and Vecata Invest have invested in LiPlasome Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
